Почетна › Неуробластом › Охајо
Kliničke studije za Неуробластом u državi Охајо
10 studija za Неуробластом traži učesnike na lokacijama u državi Охајо.
Gradovi u državi Охајо
Zvanični tekst studije (na engleskom)
Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
- Cincinnati Children's Hospital Medical Center, Cincinnati
Тражи се учесник
До 17 година · Оба пола · Ажурирано 13. 11. 2026. · NCT06831552Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Children's Hospital Medical Center of Akron, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Rainbow Babies and Childrens Hospital, Cleveland
- и још 4
Тражи се учесникФаза 3
До 30 година · Оба пола · Ажурирано 30. 10. 2026. · NCT06172296Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
- Cincinnati Children's Hospital Medical Center, Cincinnati
Тражи се учесникФаза 1
12 Months – 20 Years · Оба пола · Ажурирано 8. 10. 2026. · NCT02013336Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Rainbow Babies and Childrens Hospital, Cleveland
- Cleveland Clinic Foundation, Cleveland
- и још 3
Тражи се учесникФаза 3
365 Days – 30 Years · Оба пола · Ажурирано 25. 8. 2026. · NCT03126916Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Cincinnati Children's Hospital Medical Center, Cincinnati
Тражи се учесникФаза 1/2
12 Months – 30 Years · Оба пола · Ажурирано 25. 8. 2026. · NCT04851119Haploidentical Donor Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Neuroblastoma
- Cincinnati Children's Hospital Medical Center, Cincinnati
Тражи се учесникФаза 2
Узраст од 1 до 39 · Оба пола · Ажурирано 24. 8. 2026. · NCT07635056SPEARHEAD-3 Pediatric Study
- Cincinnati Children's Hospital Medical Center, Cincinnati
Тражи се учесникФаза 1/2
Узраст од 2 до 21 · Оба пола · Ажурирано 11. 8. 2026. · NCT05642455NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
Тражи се учесникФаза 2
Узраст од 1 до 31 · Оба пола · Ажурирано 20. 7. 2026. · NCT06450041Neuroblastoma Biology Study
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
Тражи се учесникОпсервациона студија
31 Days – 99 Years · Оба пола · Ажурирано 23. 3. 2026. · NCT01587300A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Nationwide Children's Hospital, Columbus
Тражи се учесникФаза 2
18 Months – 40 Years · Оба пола · Ажурирано 12. 8. 2025. · NCT05135975Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.